SEE HOW BIOSIMILARS ARE EVALUATED BASED ON THE TOTALITY OF EVIDENCE, INCLUDING ANALYTICAL, NONCLINICAL, CLINICAL PHARMACOLOGY, PK/PD, AND CLINICAL STUDIES.